SINO BIOPH.SUBDIV.HD-,025 revenue breakdown overview

SINO BIOPH.SUBDIV.HD-,025 revenue for the last year amounted to 3.34 B EUR, the most of which — 3.30 B EUR — came from its highest performing source at the moment, Modernised Chinese Medicines and Chemical Medicines, the year earlier bringing 3.93 B EUR. The greatest contribution to the revenue figure was made by China — last year it brought SINO BIOPH.SUBDIV.HD-,025 3.36 B EUR, and the year before that — 4.00 B EUR.